Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Transfusion. 2011 Jun 9;51(12):2647–2655. doi: 10.1111/j.1537-2995.2011.03210.x

Figure 1.

Figure 1

Impact of storage duration on the post-thaw recovery of TNCs and CD3+ cells and TNC viability in clinical donor leukocyte products. Three hundred eleven clinical leukocyte products were cryopreserved in 5% DMSO and 6% pentastarch, were stored in liquid nitrogen, and were thawed. The post-thaw recovery of TNCs for products stored for various durations of time is shown in panel A, the post-thaw CD3+ cell recovery is show in panel B and the post-thaw TNC viability in panel C. Products were grouped by those stored up to 30 days (black diamonds), 31 to 90 days (red squares), 91 to 180 days (yellow triangles), 181 to 365 days (blue Xs), 1 to 2 years (purple Xs), and more than 2 years (brown circles).